drugset / Trial / NCT04221750

Diet and Exercise Plus Metformin to Treat Frailty in Obese Seniors

NCT04221750 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The continuing increase in prevalence of obesity in older adults including many older Veterans has become a major health concern. The clinical trial will test the central hypothesis that a multicomponent intervention consisting of lifestyle therapy (diet-induced weight loss and exercise training) plus metformin will be the most effective strategy for reversing sarcopenic obesity and frailty in older Veterans with obesity.

Timeline

Start
2021-05-14
Primary completion
2025-07-31
Completion
2025-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1500 mg Oral

Indications

No indication recorded.